Skip to Main Content

Paper Details

Transcription factor MEF2D is required for the maintenance of MLL-rearranged acute myeloid leukemia.
Blood Adv
11
2021
-, AML, AML cells, Acute myeloid leukemia, CEBPE, CEBPE cis-regulatory regions, DOT1L, HOXA9, MEF2D, MLL, MLL-r, MLL-rearranged acute myeloid leukemia, MLL-rearrangement, Transcription factor MEF2D, acute leukemia, human, leukemia, myeloid cell, r AML, super-enhancer-associated, highly expressed gene, transcription factor MEF2D
Author NameAffiliation
Yang ZhouUniversity of Alabama at Birmingham
Yang ZhouUniversity of Alabama at Birmingham
Deyou ZhengAlbert Einstein College of Medicine
Deyou ZhengAlbert Einstein College of Medicine
Deyou ZhengAlbert Einstein College of Medicine
Ravi BhatiaUniversity of Alabama at Birmingham
Ravi BhatiaO'Neal Comprehensive Cancer Center, University of Alabama at Birmingham
Ravi BhatiaUniversity of Alabama at Birmingham
Ravi BhatiaO'Neal Comprehensive Cancer Center, University of Alabama at Birmingham
  • 1 - 9

Datasets

Release 1.2